Navigation Links
Study: Heart damage after chemo linked to stress in cardiac cells
Date:5/21/2012

COLUMBUS, Ohio - Blocking a protein in the heart that is produced under stressful conditions could be a strategy to prevent cardiac damage that results from chemotherapy, a new study suggests.

Previous research has suggested that up to a quarter of patients who receive the common chemotherapy drug doxorubicin are at risk of developing heart failure later in life. Exactly how that heart damage is done remains unclear.

In this study, scientists identified a protein called heat shock factor-1 (HSF-1) as a likely source of chemotherapy-related heart damage in mice and cell cultures. Heat shock factor-1 is known to be induced by stress - in this case, the chemotherapy treatment itself.

"We have found that a simple stress-related factor could be aggravating chemotherapy's effect on the heart," said Govindasamy Ilangovan, associate professor of internal medicine at Ohio State University and senior author of the study. "The results are leading us toward the idea that any additional stress could hurt the heart more than what chemotherapy itself can do."

The researchers gave doxorubicin to two sets of mice - normal animals and mice that were genetically altered so they could not produce HSF-1. Mice without HSF-1 had healthier hearts and lived longer after the chemotherapy treatment than did normal mice.

A closer examination on the cellular level suggested that when HSF-1 is blocked in the heart, this condition allows for the activation of a gene that produces a protein to pump the chemo medicine out of heart muscle cells, preventing these cells from dying.

Ilangovan and colleagues are working to design drugs that could selectively inhibit HSF-1 in the heart as a potential additional therapy for cancer patients undergoing chemo treatment.

The research appears this week in the Proceedings of the National Academy of Sciences Online Early Edition.

Chemotherapy targets cancer cells, but it also
'/>"/>

Contact: Govindasamy Ilangovan
Govindasamy.ilangovan@osumc.edu
614-292-9064
Ohio State University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study: Choice between stroke-prevention procedures influenced by patient age
2. UNC study: Obese 3-year-olds show early warning signs for future heart disease
3. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
4. Henry Ford Hospital study: Shoulder function not fully restored after surgery
5. Study: Federal funds support health depts., but leadership is key
6. Study: Kidney disease a big risk for younger, low-income minorities
7. Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery
8. Study: Low Levels of Vitamin D Linked to Higher Rates of Asthma in African American Kids
9. Study: Child health may suffer in strong economy
10. Study: Social influence playing role in surging autism diagnoses
11. Children's Rights Group Agrees with New Study: Infant Circumcision Causes 100 Deaths Each Year in US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 Canadian Cannabis Clinics ( ... and utilization of medical cannabis as a treatment ... doctors and clinics dedicated to providing access to ... gateway for patients searching for medical marijuana treatment ... launched their sub domain for Canada. , ...
(Date:3/27/2015)... Newport, RI (PRWEB) March 27, 2015 April ... civil war – the Sesquicentennial. To honor America’s bloodiest war ... the Fort Adams Trust presents A Tribute to the Civil ... 7:00 PM, Friday, April 17, 2015, at the Jane Pickens ... Williams, noted Civil War-Lincoln scholar, will serve as the master ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Yisrayl Hawkins, Pastor ... says the only way to live in Peace is through ... a new article published this week. , The article titled, ... state of mankind and how straying away from the original ... Yisrayl says the system that has been created in the ...
(Date:3/27/2015)... In light of two lawsuits that ... District Court, District of Massachusetts; and case number 2:15-cv-00709PD, ... Pennsylvania), the San Diego personal injury lawyers of The ... that they are available to investigate potential birth ... prescribed Zofran while pregnant and who gave birth to ...
(Date:3/26/2015)... TX (PRWEB) March 27, 2015 Moreno ... proud to announce prestigious victories at the 2015 International ... ranch was quite successful across many categories of show ... our performance at the ABBA International Brahman show,” explained ... friendly competition, and the proof of our superior genetics ...
Breaking Medicine News(10 mins):Health News:Canadian Cannabis Clinics (CCC) to Join the Canada.MarijuanaDoctors.com Network 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:Red and Gray Brahman Cattle Champions Announced by Moreno Ranches at International Brahman Show and Sale in Houston, Texas 2
... Survival times for those with malignant gliomas increased, study ... a catheter to deliver chemotherapy drugs directly into a ... early clinical trials, researchers report. , Malignant gliomas are ... Only about 3 percent of patients diagnosed with a ...
... organizational name and brand reflects regional vision for ... Bucks County.PHILADELPHIA and LANGHORNE, Pa., May 4 ... its name to Aria (pronounced ARE-EE-UH) Health. ... and brand at its existing hospital and outpatient ...
... Junghans, MD, associate professor of surgery at Boston University ... was named principal investigator of a grant to research ... to fight their disease. Junghans along with colleagues at ... Award, from the Department of Defense Breast Cancer Research ...
... activity area at May 9 eventATLANTA, May 4 ... will host the first Bright Starts Kids for the Cure Korral ... Saturday, May 9 at Atlantic Station in Midtown Atlanta, Ga. Parents ... drink as they enjoy fun activities like carnival games, caricature sketches ...
... Unwavering Commitment to Quality, for Company,s Medical DevicesPITTSBURGH, ... www.neuro-kinetics.com ), manufacturers of noninvasive medical ... vestibular, neurological and other disorders, said today that ... its nystagmograhpy-based products and services.Nystagmography is the recording ...
... there may be yet another reason to reduce childhood obesity ... the May issue of the Journal of Allergy and ... at increased risk of having some kind of allergy, especially ... Institute of Environmental Health Sciences (NIEHS) and the National Institute ...
Cached Medicine News:Health News:Delivering Chemo Directly Into Brain Tumors Shows Promise 2Health News:Delivering Chemo Directly Into Brain Tumors Shows Promise 3Health News:Frankford Hospital Changes Its Name to Aria Health 2Health News:Parents, Kids Invited to Kids Korral at Annual Komen Atlanta Race for the Cure 2Health News:Neuro Kinetics Earns ISO 13485 Certification 2Health News:New data analysis shows possible link between childhood obesity and allergies 2
(Date:3/27/2015)... , March 27, 2015 Zimmer Holdings, Inc. (NYSE ... fixation system for trauma patients. Available in ... ® External Fixation System from Zimmer is a ... materials.   The XtraFix System allows surgeons ... the external fixation process, resulting in saved time, costs and ...
(Date:3/27/2015)... 2015 CHINA AID, ... Care, Rehabilitation Medicine and Healthcare, second to none in ... be held at Shanghai New International Expo Center on ... Implementation Suggestions on Encouraging Private Capital to Participate in ... jointly issued by the Ministry of Civil Affairs of ...
(Date:3/27/2015)... Quebec , March 27, 2015  Valeant Pharmaceuticals ... today the closing of its previously announced registered offering ... (the "Offering"). Pursuant to the Offering, the ... $199.00 per share, for aggregate gross proceeds of approximately ... with the U.S. Securities and Exchange Commission a final ...
Breaking Medicine Technology:Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3
... to Block HIV Infection ... of Immune ... SGP ) today announced that it has initiated two ... once-daily as a single 30 mg tablet in combination,with an ...
... breast cancer risk in ... postmenopausal women with osteoporosis, INDIANAPOLIS, Sept. 14 Today, ... U.S. Food and Drug Administration,(FDA) has approved its osteoporosis drug ... of invasive breast cancer in two populations:,postmenopausal women with osteoporosis ...
Cached Medicine Technology:Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients 2Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients 3Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients 4FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 2FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 3FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 4FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 5FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 6
MAXM is a reliable benchtop solution for processing mid-size volume workloads. Features include three-dimensional VCS technology, continuous autoloading and easy-to-use data management capabilities....
Creatinine Test Kit (enzymatic, liquid reagents), Wavelength: 550 nm. Linear range: up to 150 mg/dL....
Intended for the quantitative determination of creatinine in serum, plasma, or urine. Reaction: Endpoint. Wavelength: 340 nm. Linearity: 10 mg/dL (880 mol/L). Two vials, dry powder reagents....
For the quantitative determination of creatine kinase in serum. Kinetic Reaction measured at 340 nm. Linearity: 1500 IU/L at 37C....
Medicine Products: